Found: 12
Select item for more details and to access through your institution.
Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421).
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0054-5
- By:
- Publication type:
- Article
Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1165188
- By:
- Publication type:
- Article
Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1137, doi. 10.1007/s00262-007-0444-7
- By:
- Publication type:
- Article
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin(R)) in patients with advanced solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 8, p. 1856, doi. 10.1002/ijc.29212
- By:
- Publication type:
- Article
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
- Published in:
- 2013
- By:
- Publication type:
- journal article
The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3636, doi. 10.1002/cncr.28285
- By:
- Publication type:
- Article
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 17, p. 4139, doi. 10.1002/cncr.26732
- By:
- Publication type:
- Article
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1149, doi. 10.1634/theoncologist.2019-0331
- By:
- Publication type:
- Article
Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/324708
- By:
- Publication type:
- Article